Biopharmaceutical

African Bundibugyo Ebolavirus Vaccine Advances to Clinical Trials

by

Minapharm Group will receive up to $16.5 million from the Coalition for Epidemic Preparedness Innovations to develop a Bundibugyo ebolavirus vaccine candidate, addressing an escalating outbreak in the Democratic Republic of the Congo, according to a joint announcement from the organizations. CEPI Funding Advances Minapharm Vaccine Candidate for DRC Outbreak Leading African biopharmaceutical company Minapharm … Read more

Mosquito Bite Vaccine: A New Breakthrough in Immunity

by

Researchers at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, have developed a new vaccination approach that uses antimalarial drug compounds to transform mosquito bites from a source of deadly infection into natural immune boosters, according to a study published in Science. Targeting the Late Liver Stage to Build Durable Immunity The preclinical … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: office@newsy-today.com

For contact, advertising, copyright, issues email: office@newsy-today.com